hyperplasia of mammary glands
Conditions
Interventions
Case series:Yanlurukang capsules
Sponsors
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed with disease of mammary gland hyperplasia; 2. Diagnosed with kidney Yang deficiency syndrome; 3. Aged between 18 ~ 50 years old women, menstrual cycle 25 ~ 35 days; 4. Voluntary participation in the clinical research and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Mastitis, mammary gland fibroma, breast simple cyst, high lactation hematic disease, breast cancer and adolescence lacteal painful disease, and other surgical indications of mammary gland disease; 2. Menopause, severe menstrual cycle disorder or functional uterine bleeding; 3. Pregnancy, lactation, or recent pregnancy planners; 4. Merge heart, brain, liver, kidney and hematopoietic system serious primary disease, psychosis, liver and kidney function was abnormal; 5. Allergic constitution or known allergy to this medicine composition; 6. Doubt or have alcohol and drug abuse history; 7. Nearly a month participated in other clinical subjects; 8. The researchers think that there are other reasons not appropriate for the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of TCM symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast pain score;clinical efficacy; | — |
Countries
China
Contacts
Public ContactYingYi Fan; XiaoMiao Zhang
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Outcome results
None listed